|
See related Ciprobay information |
|
|
|
Manufacturer |
Bayer HealthCare Pharma |
|
Distributor |
DKSH |
|
Contents |
Ciprofloxacin (Tab: HCl monohydrate; Inj: Lactate). |
|
Indications |
Infection of resp tract, middle ear, sinuses, eyes, GUT, GIT, biliary tract, skin & soft tissues, bones & joints; peritonitis, septicemia, infections in patients w/ reduced host defense, & for selective gut decontamination.
Click to view Ciprobay detailed prescribing infomation |
|
Dosage |
125-750 mg (oral) bid or 100-200 mg (IV). Acute gonorrhea Single dose of 250 mg (oral) or 100 mg (IV). Dosage must be reduced if CrCl <30 mL/min.
Click to view Ciprobay detailed prescribing infomation |
|
Overdosage |
View Ciprobay overdosage for action to be taken in the event of an overdose. |
|
Administration |
May be taken with or without food (May be taken w/ meals to minimise GI discomfort. Do not take w/ antacids, Fe or dairy products.). |
|
Contraindications |
Hypersensitivity to ciprofloxacin or other quinolones. Childn, adolescents, pregnancy & lactation.
Click to view Ciprobay detailed prescribing infomation |
|
Warnings |
For additional cautionary notes to warn of the potential risk of using the medicine... click to view Ciprobay detailed prescribing infomation |
|
Special Precautions |
Epilepsy, CNS damage.
Click to view Ciprobay detailed prescribing infomation |
|
Adverse Drug Reactions |
Nausea, diarrhoea, vomiting, dyspepsia, abdominal pain, flatulence, anorexia, dizziness, headache, tiredness, agitation, trembling. Insomnia, peripheral paralgesia, sweating, unsteady gait, convulsions, increase in intracranial pressure, anxiety states, nightmares, confusion, depression, hallucinations, impaired taste & smell, visual disturbances, tinnitus, transitory impairment of hearing, esp at high frequencies, skin reactions.
View ADR Monitoring Form |
|
Side Effects |
View Ciprobay side effects |
|
Drug Interactions |
Mineral-containing antacids reduce absorption of ciprofloxacin. May increase theophylline plasma levels. Concomitant intake w/ NSAIDs can lead to convulsion. Transient rise of serum creatinine w/ cyclosporin. Effects of warfarin are intensified.
View more drug interactions with Ciprobay |
|
Pregnancy Category (US FDA) |
Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus. |
|
Storage |
View Ciprobay storage conditions for details to ensure optimal shelf-life. |
|
Description |
View Ciprobay description for details of the chemical structure and excipients (inactive components). |
|
Mechanism of Action |
View Ciprobay mechanism of action for pharmacodynamics and pharmacokinetics details. |
